Evidence map›Paper›PMID 33732261›Full record

ArticleFrontiers in immunology2021

Association of HLA Class I Genotypes With Severity of Coronavirus Disease-19.

Maxim Shkurnikov, Stepan Nersisyan, Tatjana Jankevic, Alexei Galatenko, Ivan Gordeev, Valery Vechorko, Alexander Tonevitsky

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 90 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
90citing papers in PubMed, 2 pooled it
8.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

90 citing papers in PubMed, 2 syntheses or guidelines pooled it, 144 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Genes · 2024
    Article
  18. Narrative Review Explaining the Role ofInfectious disease reports · 2024
    Review
  19. Article
  20. Article

30 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 5 institutions in 1 country.

Maxim ShkurnikovFaculty of Biology and Biotechnology, HSE University, Moscow, Russia.
Stepan NersisyanFaculty of Biology and Biotechnology, HSE University, Moscow, Russia.
Tatjana JankevicCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, Moscow, Russia.
Alexei GalatenkoFaculty of Biology and Biotechnology, HSE University, Moscow, Russia.
Ivan GordeevCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Pirogov Russian National Research Medical University, Moscow, Russia.
Valery VechorkoO.M. Filatov City Clinical Hospital, Moscow, Russia.
Alexander TonevitskyFaculty of Biology and Biotechnology, HSE University, Moscow, Russia.
National Research University Higher School of Economics · RUPirogov Russian National Research Medical University · RUCity Clinical Hospital No15 named. O. M. Filatova · RUInstitute of Bioorganic Chemistry · RULomonosov Moscow State University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Human leukocyte antigen (HLA) class I molecules play a crucial role in the development of a specific immune response to viral infections by presenting viral peptides at the cell surface where they will be further recognized by T cells. In the present manuscript, we explored whether HLA class I genotypes can be associated with the critical course of Coronavirus Disease-19 by searching possible connections between genotypes of deceased patients and their age at death. HLA-A, HLA-B, and HLA-C genotypes of

Indexed as

GenotypeSeverity of Illness IndexAgedAged, 80 and overAge FactorsAllelesCohort StudiesCOVID-19FemaleGene FrequencyGenetic TestingHigh-Throughput Nucleotide SequencingHLA-A AntigensHomozygoteHumansMaleHLA-A AntigensCOVID-19HLA class IMHC class Ipeptide presentationSARS-CoV-2

Identifiers

PMID33732261
PMCPMC7959787
OpenAlexW3129778266

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.